.Novartis levels a brand new outpost in its partnership with Voyager Therapies, paying out $15 milli...
.On the heels of an FDA turndown for its main rivalrous Novo Nordisk, Eli Lilly is pushing on in the...
.Merely a few months after dosing the first person in a stage 2 trial for freshly diagnosed glioblas...
.Eli Lilly's search for weight problems aim ats has actually led it to the darker genome. The Big Ph...
.Collection Biosciences is going on up. The cell therapy company has added $325 million in ammunitio...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted...
.Aelis Farma's chances of securing a simple, beneficial choice on a $100 million option remittance h...
.ProKidney has ceased one of a pair of stage 3 tests for its cell therapy for renal ailment after ch...
.Vaxcyte revealed what professionals referred to as "stunning" phase 1/2 records for its 31-valent p...
.Recursion has stumbled via a very early test of its tech-enabled technique to medicine exploration,...